Tech Company Financing Transactions

Seaport Therapeutics Funding Round

On 4/10/2024, Seaport Therapeutics announced $100 million in Series A funding from Arch Venture Partners, Sofinnova Ventures and PureTech Ventures.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Healthcare Services

Mailing Address

6 Tide Street 400
Seaport Boston, MA 02210
USA

Phone

Undisclosed

Website

www.seaporttx.com

Email Address

[email protected]

Overview

Powered by our Glyph platform we are advancing first and best-in-class medicines for people living with neuropsychiatric disorders. We have a proven strategy of advancing clinically validated mechanisms -- previously held back by limitations -- which our technology platform can now overcome.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Daphne Zohar

        

Founder

Steven Paul

        

Browse more venture capital transactions:

Prev: 4/10/2024: Sortium venture capital transaction
Next: 4/10/2024: Yoshi Mobility venture capital transaction

Share this article

About Our VC Transactions Data

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary